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ABSTRACT 
Telomeres are repeated sequences located on both ends of individual chromosomes in eu-
karyotes. The sequence of human telomere DNA consists of guanine rich tandem repeats 
of (TTAGGG)n， which can be 10-15 kilobase pairs long. Telomeres progressive1y shorten 
with age or population doublings in somatic cells in culture and in vivo， since DNA and so-
matic cells do not have detectable levels of the enzyme， telomerase， which adds repeated 
te10mere sequences to the 5' ends of DNA. Telomerase activity has been detected in im-
mortalized cells in vitro and tumor cels and represents an important difference between 
normal and cancer cels. Telomere shortening has been assumed to cause a critical 
destabilization of chromosomes， growth arrest， and possibly cellular senescence. 
Telomerase activity and the maintenance of telomere length might be an obligatory step in 
the progression of human tumors and the immortalization of cells， but the basis for regula幽
tion of telomerase activity in tumor cells is unknown. 
The length of terminal restriction fragment (TRF) was studied by the Southern blot analy-
sis in hepatocellular carcinomas (HCC) and their-surrounding tissues (chronic active hepati-
tis; CAH or liver cirrhosis; LC) in 6 HCV antibody-positive， 7 HBV antigen-positive and 3 
virus-negative patients with HCC. The average TRF in al the 3 types of HCC were sig幽
nificant1y shorter than those of the surrounding tissues， i.e.， LC or CAH (P<O.Ol by 
paired t test). In order to verify the findings， the TRF of HCC， LC or CAH in additional 
6 託CV-antibody positive， 5 HBV-antigen positive and virus-negative patients were 
analyzed， and taken together， the results revealed that the TRF progressively shortened during 
hepatocarcinogenesis (normal →CAH→LC→HCC) at least in HBV…and HCV-positive patients. 
Thus， the present findings strongly support the idea that a persistant cel proliferation or 
rapid cel turnover by damage of hepatic cells results in a multistep process of hepatocar-
cinogenesis， and further indicate that the TRF reduction is strongly associated with 
hepatocarcinogenesis. (Accepted on Junuary 9， 1995) 
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1.はじめに
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図1.ヒト染色体末端粒(テロメア)の l例
この例では約10KbのTTAGGGの反復配列と，約4Kbのサブテロメア領域が示されている(臨床分子医
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y= -37.4 x+7705.7 
x:年齢
y : bp 






直線の傾きは， -37.4bp/yearで， テロメアは l年当たり37.4bp短くなる計算になる.
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1984: B cell prolymphocytic leukemia 
1985: malignant fibrous histiocytoma 
1986: pre T cell acute lymphoblastic leukemia 
1987: human renal tumor 
cardiac myxomas 
1990: human colorectal carcinoma 
ovarian tumor 
lung tumor 
1992: acute leukemia and remission 
neuroblastoma 
1993: chronic myeloid leukemia and acute lymphoblastic 
leu主e臨ia












































Case N o. Diag.(Ed.Gr.) HCC size * chemo. TRF 
(Se x， Ag e) (mm) (Kb) 3 4 5 6 7 8 9 10 
HCV HCC (蕊) 36 + 5.1 
(M，46) 
CAH 8.3 
HCC (1) 55 4.9 
2 (M，56) I ~~~ 9.4 
HCC ( m) 108 十 4.7 
3 (M，59) I CAH 6.8 
HCC ( n) 50 十 4.2 
4 (F，64) I L C 5.2 
HCC (1 > n ) 20 3.7 
5 (F，70) I L C I 5.2 
HCC ( m) 42 一 3.6 
6 (M，72) 
L C 5.0 
7 (M，57) HCC( n >蕊) 45 十 5.0 
8 (M，60) HCC( 1 > n) 60 5.2 
9 (M，63) 十~CC (1) 17 + 3.6 
O (F，66) HCC( n >班) 25 I 4.8 
1(M，74) I HCC( n > 1) 66 十 I3.5 
12 (M，54) IしC N.A. N.A. I 6.2
性加，年齢，病変組織の診断，エドモンドソン分類，臆蕩径，化学療法の有無， TRFを示す. (Di-
ag. : Diagnosis， ED. Gr. : Edmondson grade， chemo. : chemotherapy) 
神経芽細抱躍でのテロメア長の短小化が，病変の
































Case N o. Diag.(Ed.Gr.) HCC size* chemo. TRF 
(Se x， Ag e) (mm) (Kb 3 4 5 6 7 8 9 10 
HBV HCC (耳) 147 + 6.2 
(F，43) 
CAH 6.8 r; 万ι乙乙〆ノ ヨ
HCC (m) 40 十 3.2困
2 (M，55) 
CAH 6.0 ~シシシシシシシシシ~/~
HCC (n) 100 十 5.2 
3 (M，62) 
CAH 5.4ルシシシシシシシシシゲノ
HCC (m) 65 十 3.6 
4 (M，65) 
CAH 5.4防シシシシシシシ~h川
HCC (n) 20 + 4.2 
5 (F，56) 
L C 5.2 
HCC (1) 22 + 5.2 
6 (M，60) 
L C 5.4 
HCC (1) 19 十 5.9 
7 (F，63) 
しC 6.6 
8 (M，43) HCC (互) 129 3.9 
9 (M，53) HCC (m) 100 十 6.1 
10 (M，56) L C N.A. N.A. 5.4 
11 (M，62) しC N.A. N.A. 6.0 




































Case No. * TRF Diag. (Ed.Gr.) H~~~ir chemo. 
(S e x噌 Age) (Kb) 3 4 5 6 7 8 9 10 
HCC (立) 74 + 4.0 
NV-1 (M，59) 
L C 5.4 
十-lCC (I) 20 + 4.8 
2 (F，65) 
CAH 9.4 I7hをV/////////////777///A
HCC (ll) 36 5.2 
3 (M，68) 
6.0協preしC
4 (M，66) HCC (ll>ID) 42 ÷ 6.6 
N-1 (M，13) Normal Liver N.A. N.A. 10.6 
2 (M，61) Normal Liver N.A. N.A. 7.8 1 
3 (M，70) Normal Liver N.A. N.A. 8.3 
4 (M，79) Normalしiver N.A. N.A. 8.9 
一






restriction fragment: T R F )を求め，表 1~表
3を得た.このようにサザンプロット法により概
定したTRFの各データを癌部・非癌部のペア間































徴小肝癌の発見のための腹部エコー (US)， C 
T， MR I.血管造影 (Angiography)などの画
像診断，腫蕩マーカーでの診断など早期発見，経
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事実，現在まで， N-ras， lca， c-myc， est2， 
HIP， IGF-]lなどのオンコジーンやプロトオン
コジーンの活性メカニズムに加え12)23)，P K C (α 
. Etype)などの発癌への関与や，さらにヘテロ接
合性の喪失 (L0 H : Loss of heterozygosity)が
染色体1p24) ， 4p， 4q， 5q， 8p， 10q4)， IIp， 13 






たり、 cell cyc1eのG1/ S移行期でCd k 2 
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図13.AAH患者の腫蕩部と非腫蕩部をHCC患者の癌部と非癌部で比較したサザンプロット. (L: 




部組織 (LC)より腫蕩部 (AAH)の方が， TR 
Fが短小化しており(図13)，AAHのTRFは






(Se x， Ag e) Diag. (Ed.Gr.) Si;.~.-(~m) chemo.I'(Kb)1 3 4 5 6 7 8 9 10 
HCV HCC (1) ll) 20 
(M，59) しC 5.4 
HCV AAH 20 4.0 
2 (M，54) しC 6.1 
HBV (立) 20 十 5.0 
3 (F，56) L C 5.4 
NV (豆) 74 十 3.0 
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